PDL BIOPHARMA INC's ticker is and the CUSIP is 69329Y10. A total of 4 filers reported holding PDL BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $43,712,000 | – | 5,662,183 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,309,377 | $10,436,000 | 0.07% |
| NJ State Employees Deferred Compensation Plan | 8,000 | $64,000 | 0.01% |
| INGALLS & SNYDER LLC | 25,600 | $204,000 | 0.01% |
| State of New Jersey Common Pension Fund A | 245,000 | $1,953,000 | 0.01% |